$0.35
-0.05 (-12.59%)
Open$0.38
Previous Close$0.40
Day High$0.38
Day Low$0.33
52W High$2.75
52W Low$0.23
Volume—
Avg Volume81.17M
Market Cap8.07M
P/E Ratio—
EPS$-3.34
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+10,801.0% upside
Current
$0.35
$0.35
Target
$37.99
$37.99
$25.94
$37.99 avg
$62.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 31.17M | 24.69M | 257.5K |
| Net Income | -62,593,891 | -44,635,529 | -16,876 |
| Profit Margin | -200.8% | -190.8% | -6.6% |
| EBITDA | -62,954,132 | -47,386,439 | -21,131 |
| Free Cash Flow | — | — | -13,268 |
| Rev Growth | +26.2% | +26.2% | +2.0% |
| Debt/Equity | 0.08 | 0.08 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $250.82 | +0.83% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $417.84 | +0.40% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.14 | +1.67% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $516.44 | -1.77% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $805.97 | +1.00% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.12 | +1.42% | 35.2 | 28.41B |